WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.
CLSI brings together the worldwide laboratory community to advance a common cause.
Streamline your breakpoint implementation process to meet new CAP requirements effective January 2024, with the Breakpoint Implementation Toolkit (BIT). To make breakpoint updates easier, CLSI has developed—in partnership with APHL, ASM, CAP, and CDC—a comprehensive and user-friendly BIT.
Dates: May 18—June 6, 2023
Groups Meeting: The Subcommittee on Antimicrobial Susceptibility Testing
Location: Virtually in May and In-person in June in St. Louis, Missouri, USA
This guideline describes five requirements for managing laboratory processes and provides suggestions for effectively meeting regulatory and accreditation requirements, assessing process risks, optimizing efficient use of resources, and contributing to patient safety and positive outcomes.
This report highlights the need for semantic interoperability and how patient care is improved through its use.
This guideline provides recommendations for establishing and verifying shelf-life and in-use stability claims for in vitro diagnostic medical laboratory test reagents such as reagent kits, calibrators, and control products.
CLSI and our volunteer members actively identify and develop new guidance on standards that raise laboratory testing quality, safety, and efficiency. We are setting the bar for how that guidance is delivered. CLSI and our volunteer members actively identify and develop new guidance on standards that raise laboratory testing quality, safety, and efficiency. We are setting the bar for how that guidance is delivered.
Learn more